Opportunity Information: Apply for RFA AT 22 001
The NIH Health Care Systems Research Collaboratory funding opportunity (RFA-AT-22-001) supports large, practical studies designed to improve health outcomes for underserved patient populations in the United States. It is aimed at generating real-world evidence about health care strategies, clinical practices, and care delivery procedures as they are actually used in everyday health care settings, rather than in tightly controlled academic or laboratory environments. The expectation is that findings will be useful not only to researchers, but also to policy makers, payers, clinicians, and patients across a wide range of care settings, especially where communities have experienced disproportionate disease burden and persistent gaps in care.
The award uses a phased UG3/UH3 cooperative agreement structure. Applicants submit one combined application that covers both phases. The first phase (UG3) is a one-year, milestone-driven planning and feasibility period where teams finalize key elements needed for a successful embedded pragmatic trial or implementation study, such as operational readiness, workflow integration, data access and quality, recruitment and retention approaches in routine care, and coordination across participating systems. Only projects that meet predefined scientific milestones and feasibility requirements during UG3 are eligible to transition to the second phase (UH3), which supports the full implementation and conduct of the pragmatic trial or implementation study. Because this is a cooperative agreement, NIH has an active partnership role, meaning awardees should expect ongoing collaboration, shared problem-solving, and coordinated expectations rather than a fully hands-off grant mechanism.
A central requirement is that the intervention being tested must be embedded within health care delivery, meaning it needs to fit into real-world workflows and systems of care. Studies can test the integration of one intervention or multiple components, including multi-modal approaches, as long as the underlying strategies have demonstrated efficacy and the proposed work focuses on pragmatic evaluation or implementation at scale. Projects may also focus on health care system changes that increase adherence to evidence-based guidelines, such as clinical decision support, care pathway redesign, team-based care modifications, population health management processes, or other system-level approaches that improve uptake and consistent delivery of proven practices.
The FOA emphasizes multi-system, scalable research. Proposed trials or studies must be conducted across three or more health care systems that provide care to underserved populations. Awardees become part of and work with the NIH Health Care Systems Research Collaboratory, a national program designed to strengthen how embedded research is planned and executed in partnership with health care systems. The Collaboratory includes a Collaboratory Coordinating Center (CCC) that provides leadership and technical expertise across major domains of embedded research in health care systems, helping projects address common challenges such as stakeholder engagement, ethics and regulatory considerations in pragmatic trials, data harmonization and quality, operational integration, and dissemination planning.
Eligibility is broad within the United States and includes many types of domestic organizations and governmental entities. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses); and small businesses. The FOA also highlights participation by institutions and organizations that often serve underserved communities, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, as well as faith-based or community-based organizations and certain regional organizations.
Foreign participation is not allowed under this announcement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as NIH defines them) are not permitted. In short, the work is intended to be designed, led, and carried out within U.S.-based systems serving U.S. patient populations.
Administratively, the opportunity is offered by the National Institutes of Health as a discretionary program using the cooperative agreement funding instrument, within education and health-related activity categories. It references multiple CFDA numbers (93.213, 93.233, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.866), reflecting the multi-institute nature of NIH support for pragmatic and implementation research topics. The original closing date listed for this FOA was June 17, 2022, and the FOA was created on October 14, 2021.Apply for RFA AT 22 001
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.233, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.866.
- This funding opportunity was created on 2021-10-14.
- Applicants must submit their applications by 2022-06-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
Previous opportunity: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 22 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 22 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinical Research Education and Career Development (CRECD) Program (R25-Independent Clinical Trial Not Allowed) Apply for PAR 21 347 Funding Number: PAR 21 347 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Apply for PAR 22 049 Funding Number: PAR 22 049 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) Apply for RFA CA 21 063 Funding Number: RFA CA 21 063 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA CA 21 047 Funding Number: RFA CA 21 047 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required) Apply for RFA CA 21 045 Funding Number: RFA CA 21 045 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA CA 21 046 Funding Number: RFA CA 21 046 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AT 22 002 Funding Number: RFA AT 22 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) Apply for RFA AT 22 005 Funding Number: RFA AT 22 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) Apply for RFA AT 22 004 Funding Number: RFA AT 22 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 22 062 Funding Number: PAR 22 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 22 061 Funding Number: PAR 22 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 22 003 Funding Number: RFA CA 22 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 22 004 Funding Number: RFA CA 22 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Apply for RFA CA 21 062 Funding Number: RFA CA 21 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Apply for RFA CA 21 061 Funding Number: RFA CA 21 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) Apply for RFA CA 21 060 Funding Number: RFA CA 21 060 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) Apply for RFA DA 22 036 Funding Number: RFA DA 22 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) Apply for PAR 22 032 Funding Number: PAR 22 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Apply for PAR 22 071 Funding Number: PAR 22 071 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 22 001 Funding Number: RFA CA 22 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 22 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
